Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

CRISPR & Cas Genes Market Growing funding in gene therapy worldwide is a prominent factor driving the CRISPR & Cas genes market.

Successful clinical trials in autoimmune diseases could significantly enhance CRISPR Therapeutics' market position. The company's CTX112 program, which has shown promising results in B-cell ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

The FDA has approved clinical trials for organ transplants using genetically modified pigs, starting with six patients with ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.